Insights On Drug Development

  1. Improving Clinical Translation For ADCs And Immuno-Oncology With Human-Relevant Tumor Models 9/17/2026

    When preclinical tumor models fail to reflect clinical reality, promising therapies pay the price. This webinar examines how advanced patient-derived organoids and 3D models improve predictive accuracy for ADC and immuno-oncology programs.

  2. Can Targeted LNP Delivery Take In-Vivo CAR-T Therapy Beyond The Liver? 9/17/2026

    Achieving successful extrahepatic CAR T delivery with LNPs requires addressing the unique biological and technological barriers and designing targeting approaches that leverage innovative LNP design.

  3. The Phase 2 Manufacturing Wall: The CMC Risk Hiding In Plain Sight 9/17/2026

    Hidden gaps in process maturity and organizational alignment can derail development. Discover how to identify risks early and improve readiness for key milestones.

  4. The New-Age CRDMO: Rethinking Drug Development Partnerships 9/16/2026

    Navigating complex modalities requires moving beyond fragmented outsourcing. Discover strategies for strengthening supply chain resilience, maximizing global infrastructure, and leveraging data.

  5. GLP-1 Peptides Around The World Part III: EU Evolution – Expanded Expectations And Emerging Enforcement 9/15/2026

    Navigating GLP-1 development in Europe? Discover how stricter CMC, Annex 1, serialization, and supply chain requirements are influencing manufacturing strategies.

  6. Analytical Method Development For Paediatric Oral Dose Products 9/9/2026

    This article explores the key formulation and analytical challenges that pharmaceutical companies face when creating safe, effective, and age-appropriate treatments for paediatric populations.

  7. Precision In Miniature: Optimizing Multiparticulate Formulations For Pediatric Oncology 9/9/2026

    When an oral liquid formulation of crizotinib failed pediatric trials due to intolerable taste and irritation, a multiparticulate approach offered a technically demanding but viable path forward.

  8. Continuous Lyophilization: Accelerating Freeze-Drying Development 9/9/2026

    Continuous lyophilization is compressing freeze-drying cycle times from days to hours. This webinar examines how the approach is being implemented in development labs with a path to GMP manufacturing.

  9. Overcoming The Obstacles Of Spray-Dried Dispersion Scale-Up 9/9/2026

    SDD scale-up introduces scale-dependent risks that threaten bioavailability, stability, and manufacturability. This white paper details a model-based framework for managing those risks from early feasibility through commercial production.

  10. Controlling Complexity In ADC Formulation Development 9/9/2026

    ADC formulation development requires a molecule-specific approach that accounts for the interplay between antibody, linker, and payload, and the stability trade-offs that mAb development experience cannot fully anticipate.